<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 61 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page60.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=61">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 61 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 61</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=61"><img src="../thumb/61.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>30 / 2020-04                                                        Central Nervous System - 1.5.3
   eride ser.elevat., headache, abdom./back/chest/ear pain, hypertens.,   suicidal., observ.same precaut.as those for other psych./ non psych.  nightmare, anorgasm., tard.dyskines., convuls., syncope, psychomot.
   myalg., anx., dry eyes, UTI, extrapyramid. sympt., prolongat. of QTc   disord., cons.chang.ther.regim./ discont. if psych.sympt.occur which   hyperactiv., postur.disturb.in attent., dysarthria, dysgeus., hypoaes-
   interv., liv. enzyme abnormalit.  are sev./ abrupt in onset/not part of pres.sympt., taper dos. when   thes., paraesthes., neurolept.malign.syndr., rhabdomyolys., cerebr.
   Special precautions: Monit.gluc.contr.of exist. diabet./hypergly-  discont., stroke risk fact., monit.elderly esp. dur. init. dos.per., monit.  ischaem., unrespons.to stimuli, loss of/depress.lev of conscious.,
   caem.sympt.in those at risk, cont. anti-diab.meds.poss.necess.de-  gluc.contr.of exist.diabet./ hyperglycaem. sympt.in those at risk, those   bal. disord., blurr.vis., conjunctivit., dry eye, eye movem. disord.,
   spite ther. discont., other CNS act. drugs & alcoh., elderly esp. init.,   develop. hyperglycaem.sympt.dur.ther.to undergo fast. bld.gluc.test,   photophob., incr.lacrimat., ocul. hyperaem., vertigo, tinnit., ear pain,,
   sev.ren.impairm., hepat.impairm., known CV dis., cerebrovasc.dis./  contin.anti-diab.meds.poss. necess. despite ther.discont., concom.  bradycard., tachycard., atrial fibrillat., AV block, QT prolongat., postur.
   other condits. predispos.to hypotens., concom.meds.known to pro-  alcoh./other central. act.meds., known CV/cerebrovasc.dis./ condits.   orthostat.palpitat., abnorm. ECG, sinus dysrhythm., hyper-/hypotens.,
   long QTc interv., seiz.hist., consid.discont.if S&S of tard.dyskines.  predispos.to hypotens., concom.meds. known prolong.QTc interv.esp.  DVT, flush., cough, nas. & resp.tract congest., dyspn., pulm. congest.,
   occur, discont.if sympt.of neurolept. malign.syndr.occur, poss.dos.  in elderly, seiz.hist., cons. ther.discont.if S&S of tard.dyskin.occur, dis-  wheez., pharyngolaryngeal pain, toothache, dyspeps., gastroenter-
   adjustm. with carbamazepine/phenytoin/other concom. hepat. en-  cont. ther./appropr.treatm.admin.in case of neurolept. malign.syndr.,   it., dry mouth, flatul., pancreatit., swollen tongue, faecal incontin.,
   zyme induc., reduc.dos.dur.concom. potent. CYP3A4 inhibit.(e.g.azole   concom.grapefruit juice not recomm., concom.hepat.enzym.induc.  faecaloma, dysphag., incr. transaminase., gammaglutamyltransferas.
   antifung./ macrolide antibiot. & protease inhib.) ther., consid. benef./  Drug interactions: Incr.clear.with thioridazine, decr.plasma conc.  incr., incr. hepat.enzyme, skin rash, urticar., prurit., alopec., eczema,
   risk assessm. for contin.ther.at high.dos., leucopaen.&/neutropaen.  with strong hepat.enzym.induc. e.g. carbamazepine/phenytoin/  dry skin , erythema, acne, drug erupt., hyperkeratos, dandruff, back
   resolv. aft. discont.ther., risk fact.for leucopaen. & /neutropaen. incl.  other hepat. enzym. induc.such as barbits./rifampicin, signif.incr.  & neck pain, musc. sp.& weakn., joint stiffn.& swell., arthralg., incr.
   pre-exist.low WBC/drug induc. hist. thereof., withdr.grad., compar.to   AUC with ketoconazole.  bld.creatine phosphokinase, urin.incontin./-retent., pollakiur., dysur.,
   placebo elderly pts.with dement.-relat.psychos.at incr. risk of death  gynaecomast., erect. dysfunct., sex.dysfunct., galactorrh., amenor-
   Drug interactions: Incr.clear.with concom. thioridazine/ carbamaz-  TRUVALIN, (Cipla Medpro) AstraZeneca [P/S]  rh., menstr. irregul., breast/vag.discharge, breast pain/-engorgem./-
   epine/phenytoin/other hepat. enzyme induc, mean half life incr.  Quetiapine.  enlargem./-discharge/-discomf, pyrex., fatig., abnorm.gait, chest
   with ketoconazole.           Indications: Schizophren., bi-polar disord. assoc. manic episod.for   pain/ discomf., face oed., oed., malaise, indurat., hypotherm., chills,
                                which safety & effic. beyond 12 wks.not demonstrat.
   SOLIAN, Sanofi-Aventis [P/S]  (S5) TABS. 43/2.6.5/0159, 0160, 0161, 0162  incr./decr.body temp., thirst, fall. Post market: Agranulocytos., water
                                                              intoxicat., diabet.ketoacidos., anaphylact.react.& in pts.who prev.tol.
   Amisulpride                  716646-001: 25 mg, 100, R254,00  oral risperidone/oral paliperidone, cataton., blunt.affect, somnambul.,
   Indications: Ac.& chron.schizophren.incl.pts. charact. by predomin.  716647-001: 100 mg, 90, R432,53  sleep-relat. eat. disord., diabet.coma, abnorm.co-ordinat., head intitu-
   negat.sympts.                716648-001: 200 mg, 60, R465,58  bat., glauc., intraop.floppy iris syndr., pulm. embol., ischaem., sleep
   (S5) TABS, 34/2.6.5/0116, 0117  716649-001: 300 mg, 60, R544,20  apnoea syndr., hyperventilat., pneumon.aspirat., dysphon., intestin.
   892309-005: 50 mg, 30, R241,04  Dosage: Adults: Admin.twice dly.  obstruct., cheilitis., paralyt.ileus, jaund., seborrh. dermatit., angioed.,
   892310-001: 200 mg, 30, R817,60  Schizophren: Tot.dly.dos.for 1  4 days: Day 1: 50 mg, day 2: 100 mg,   skin discolourat., abnorm. posture, neonat.drug withdr.syndr., pria-
                                             st
   Dosage: Specif.titrat.not reqd.when init.treatm. Indiv.accord.to   day 3: 200 mg & day 4: 300 mg. Titr.dos.from 4  day to effect.dos.  pism, drug withdr.syndr.
                                                    th
   respons. Admin.dos.of upto 400 mg as once dly. dos.& high dos.  range of 300-450 mg/day. Adj.dos.in some pts.within 150-750 mg/  As its an act.metabol.of risperidone addit.AE’s report. with risperi-
   admin.2xdly.                 day range depend.on clinic.response & tolerab.  done: cerebrovasc.disord., rales, inj. site necros./ulc.
   Ac.schizophren: Recom.dos.: 400-800 mg/day. May be incr.to   Bipol.disord.assoc.manic episod: Tot.dly. dos. for 1  4 days: Day   Warnings and special precautions: Discont.if neurolept. malign.
                                                       st
   1200 mg/day. In pts.with mix.posit. & negat.sympts.dos.should be   1: 100 mg, day 2: 200 mg, day 3: 300 mg & day 4: 400 mg. Furth.dos.   syndr./S&S of tard.dyskines. develop, concom.psychostimul.as tard.
   adjust.to optim. contr. of posit.sympts.& maint.est.on low.effect. dos.   adjustm. upto 800 mg/day by day 6 in increm.of no great.than 200   dyskines. observ.when adjust.eith./both treatm., monit. WBC.in hist.
   In pts.with predom.negat.sympts.indiv.dos. betw.50-100 mg/day.  mg/day. Adjust dos.accord.to clinic.respon. & tolerabil.with range of   of/drug induc.leucopen/neutropen., VTE risk fact., monit.gluc.con-
   Contraindications: Concom.meds.that induc./ enhanc.torsades   200-800 mg/ day. Usual effect.dos.: 400-800 mg/day.  trol of exist.diabet./ hyperglycaem.sympts.in those at risk, sympts.
   de pointes risk &/ prolong QT-interv., congenit.QT-interv.prolongat.,   Elderly: Init.25 mg/day, theraft.incr.dly.dos.in increm. of 25-50 mg.to   of intestin. obstruct./Reye’s syndr.& brain tumour poss. mask.due to
   concom. prolact.-depend. tumours, phaeochromocyt., childr. und.15   an effect.dos.poss.low. than young.pts.  anti-emet.eff., intraoperat. floppy iris syndr.observ.dur.cataract surg.
   yrs., pregn.& lactat., women of childbear. potent.unless tak.adeq.  Contraindications: Safety in pregn.& lactat. not est., safety & effic.  in pts. treat.with alpha1a-adrenerg.antagon.eff.theref. advise sur-
   contracept., mod.-sev.ren. funct.impairm.  in childr.& adolesc.not est., safety in advanc.liv.& ren.impairm.not est.,   geon prior to surg., card.dysrhythm. hist., congenit.long QT syndr.,
   Side effects: Neurolept.malign.syndr., QT-prolongat., torsades de   rare heredit. galact.intol., lapp-lact.defic., gluc-galact. malabsorpt., not   meds.known to prolong QT interv., card.vasc.& cerebrovasc.dis.,
   pointes, dos.relat. extrapyramid. sympts., ac.dyston., tard.dyskines.,   approv.for dement.-relat. psychos.  predisposit.to hypotens., seiz hist./condits.low. seiz.threshold, con-
   seiz., insomn., somnol., anx., agitat., incr.prolact. lev., GI disturbs.,   Side effects: Hyperglycaem.sometim.extreme assoc.with ketoaci-  dits.elev.core body temp., meds. with anticholin.activ., dehydrat., de-
   hypotens., bradycard., hepat. enzyme elevat., hyperglycaem., allerg.  dos./hyperosmol.coma/death, somnol., dizzin., dry mouth, asthen.,   term. ability to drive/operate danger.mach., concom. risperidone not
   reacts., weight gain.        constip., tachycard., orthostat.hypotens.esp.dur.init.titr. period &   recomm., data involv.other concom. antipsychot.limit., concom.oral
   Special precautions: Hyperglycaem.assoc.with ketoacid./hyper-  more in elderly, dyspeps., weight gain., syncope, neurolept.malign.  paliperidone not recomm., discont.prev.oral antipsychot. grad.at time
   osmol.coma or death report.with some atypic.antipsychot.agents,   syndr., bld.disords., periph.oed., headache, anx., rhinit., UTI, seiz.,   of init.treatm., excret.in breast milk, not stud.in sev.hepat.impairm.,
   diab.mellit., risk fact. for diab.mellit., discont.all antipsychot.meds. if   hypersens.reacts.incl.angioed./anaphylax., elev. ser.transamin.,   not recomm. in mod/sev.ren.impairm., safety & effic. in pts.und.18
   hypertherm.evid., epilep., low.seiz.threshold., Parkinson’s, recomm.  cholesterol & triglyceride ser. elevat., decr.in thyroid horm.lev., pria-  yrs.not est., safety in pregn.not est., neonates expos.dur.3  trimester
                                                                                      rd
   to monit.bradycard./ hypokalaem./ congenit.prolongat.of QT-interv/   pism, extrapyramid. sympt., prim.CNS effs., potent. tard. dyskines.,   of pregn at risk of poss. sev.extrapyramid/withdr.sympts., not stud.
   meds likely to produc.aforement., elderly, antiparkinson. medicat.may   ac.withdr.sympts.with abrupt cessat.   in elderly with dement.,
   aggrav.tardiv. dyskines. sympts  Special precautions: Elderly esp.dur.init.dos. per., monit.gluc.  Interactions: Meds.known to prolong QT interv., other concom.centr.
   Drug interactions: Centr.effs.of alcoh.enhanc., reciproc. antagon.  contr.of exist.diabet./ hyperglycaem. sympt.in those at risk, pts. de-  act.meds., may antagon.eff. of levodopa & other dopamine agonists,
   effs.betw.levodopa & neurolept., take into account CNS depress./  velop. hyperglycaem.sympt.dur.treatm.to undergo fast. bld.gluc.test.,   addit. hypotens. eff.with meds.hav.this potent., carbamazepine may
   sedat.H 1 antihistam./ barbitur./benzodiazep./other anxiolyt. meds./   cont.anti-diab.meds. poss. necess. despite ther.discont., ren./hepat.   decr.plasma lev., concom. psychostimul. as tard.dyskines.observ.when
   clonidine & its derivat./hypotens.meds.  impairm., known CV/cerebrovasc.dis./other condits. predispos.to   adjust. eith./both treatm.,
   SPEC QUETIAPINE, Specpharm [P/S]  hypotens., seiz.hist., consid. discont.if S&S of tard.dyskines.occur,   See also MDR page 433.
                                discont. if sympt.of neurolept.malign.syndr.occur & admin.appropr.
   Quetiapine.                  med.treatm., withdr.grad.over at least 1-2 wks., cont.lactose, con-  ZAMBIQUET, (Unicorn) Zimbili [P/S]
   Indications: Schizophren., manic episod.assoc. with bi-polar disord.  com.meds. prolong. QTc interv.esp.in elderly, incr.death risk in elderly   Quetiapine.
   for which safety & effic. beyond 12 wks.not demonstrat.  with dement.-relat.psychos., poss.dos. adjustm. with phenytoin/car-  Indications: Schizophren.
   (S5) TABS. 46/2.6.5/0081, 0082, 0083, 0084, 0085  bamazepine/other concom .hepat.enzyme induc., assess benef./risk   (S5) TABS. 43/2.6.5/0318, 0319, 0321, 0684
   720893-001: 25 mg, 100, R263,45  if contin.treatm.consid.at high.dos.than indic., reduc. dos.with con-  3000339-001: 25 mg, 100, R241,50
   720894-001: 100 mg, 90, R436,56  com.potent CYP3A4 inhibits., concom. other CNS act.meds.& alcoh.  3000378-001: 100 mg, 90, R408,25
   721710-001: 150 mg, 90, R715,65  Drug interactions: Incr.clear.with concom. thioridazine/ carbamaz-  3000379-001: 200 mg, 60, R423,20
   720896-001: 200 mg, 60, R487,11  epine/phenytoin/other hepat. enzyme induc., mean half-life incr.  3000380-001: 300 mg, 60, R517,50
   720897-001: 300 mg, 60, R569,69  with ketoconazole.        Dosage: Adults: Admin.twice dly.
   Dosage: Adults: Admin.twice dly.                           Tot.dly.dos.for 1  4 days: Day 1: 50 mg, day 2: 100 mg, day 3: 200 mg
                                                                     st
                st
   Schizophren: Tot.dly.dos.for 1  4 days: Day 1: 50 mg, day 2: 100 mg,   XEPLION, Janssen [P/S] &  & day 4: 300 mg. Titr.dos. from 4  day to effect.dos.range of 300-
                                                                            th
   day 3: 200 mg & day 4: 300 mg. Titr.dos.from 4  day to effect.dos.  Paliperidone  450 mg/ day. Adjust dos.in indiv.pts.within range of 150-750 mg/
                       th
   range of 300-450 mg/day. Adjust.dos.within 150-750 mg / day range   Indications: Schizophren.& prev.of recurr.of schizophren.sympts.  day depend.on clinic.response & tolerab.
   depend.on clinic.respons.& tolerab. Max. dly.dos: 750 mg.  (S5) PR SUSP FOR IM INJ, 44/2.6.5/0866, 0867, 0868, 0870  Elderly: Init.25 mg/day, theraft.dos.may be incr. dly. in increm.of 25-
   Bipol.disord.assoc.manic episod: Tot.dly.dos. for 1  4 days: Day   718469-001: 50 mg, 1xpre-fill.syr., R2 616,44  50 mg.to an effect.dos.likely. low.than in young.pts.
                         st
   1: 100 mg, day 2: 200 mg, day 3: 300 mg & day 4: 400 mg. Furth.  718470-001: 75 mg, 1xpre-fill.syr., R3 924,67  Contraindications: Safety in pregn.& lactat.not est., safety & ef-
   dos.adjustm. up to 800 mg /day by day 6 in increm.of no great.  718471-001: 100 mg, 1xpre-fill.syr., R5 232,89  fic.in childr.& adolesc.not est., safety in advanc.ren.& liv.impairm.not
   than 200 mg/day. Adjust dos.depend.on clinic.respon. & tolerabil.  718472-001: 150 mg, 1xpre-fill.syr., R7 849,33  est., elderly pts. with dement.exhibit.behav.disturbs.
   within range of 200-800 mg/day. Usual effect. dos.: 400-800 mg/  Dosage: Est.toler.with oral paliperidone/ risperidone prior to init.  Side effects: Freq: Somnol, dizzin., constip., postur. hypotens., dry
   day. Cons.indiv.benef.vs risk assessm.for contin.ther.with high.dos.   treatm. Admin.as sngl.inj. Do not admin.dos.in div.inj.  mouth, dyspeps., liv. abnormalit., trans.leucopen., neutropen., eosino-
   Max. dly. dos: 800 mg.       Init.150 mg on day 1 and 100 mg 1 wk.thereaft.in delt.musc. Maint:   phil., headache, tachycard., rhinit., asthen., incr. ALT/AST. Less freq:
   Elderly: Init.25 mg/day, theraft.incr.dly.dos.in increm. of 25-50 mg   75 mg mnthly.with recomm. range of 25-150 mg bas.on indiv.tol.&/  Angioed., anaphylax., urticar., rash, hyperglycaem., diabet.mellit./ ex-
   to effect.dos.               effic. Consid. prolong.rel.characterist.when adjust.as full eff.poss.not   acerbat. of pre-exist.diabet.mellit., seiz., tard. dyskines., extrapyramid.
   Contraindications: Safety in pregn.& lactat. not est., safety & ef-  evid.for sev.mnths. To avoid miss. mnthly. dos.inj.may be giv.up to 7   sympts., dry eyes, QTc interv. prolongat., abdom.pain., priapism, fev.,
   fic.in childr.und.18 yrs.not est., safety not est. in advanc.liv./ren.funct.  days bef./aft. mnthly timepoint. If target date miss.see lit for re-init.  periph. oed., weight gain, NMS, incr.GGT/non-fast. ser. triglycer./tot.
   impairm., concom. cytochrome P450 3A4 inhib.e.g. HIV prot. inhibit./  proced. When switch.from other antipsychot long act.inj.init.Xeplion   cholester. Unknown freq: Hypertens., asymptomat.lens.changes
   azole antifung.agents/erythromycin/ clarithromycin/nefazodone,   in place of next sched.inj.  with long-term treatm., diarrh., rash, myalg., ear/back/chest pain, UTI.
   dement.-relat. psychos., lact.intol.  Contraindications: Risperidone hypersens., mod. to sev.ren.im-  Warnings and special precautions: Taper dos. with discont.,
   Side effects: Hyperglycaem.sometim. extreme assoc. with ketoaci-  pairm., Parkinsons dis., dement.with Lewy Bodies.  monit.gluc.contr.of exist.diabet./ hyperglycaem. sympt.in those at
   dos./hyperosmol. coma/death, CNS effs., somnol., dizzin., dry mouth,   Side effects: Insomn., headache, anx., URTI, inj.site reacts., par-  risk, pts.develop. hyperglycaem. sympt.dur.ther.to undergo fast.bld.
   asthen., GI /psych.disords., tachycard., orthost.hypotens., weight gain,   kinsonism, weight gain/loss, akathis., agitat., somnol., naus., con-  gluc. test, cont anti-diab.meds.poss.necess.despite ther.discont., mild
   NMS, bld.dyscras., periph.oed., hypersens. reacts.incl.anaphylax.,   stipat., dizzin., musculoskelet.pain/-disords., tachycard., trem.,   to mod.ren./hepat.impairm., known cerebrovasc.dis/CV dis/condits.
   seiz., headache, extrapyramid.syndr./sympt., dry eyes, ear/chest/ back   abdom.discomf., vomit., diarrh., fatig., dyston., UTI, flu, bronchit.,   predispos. to hypotens.& seiz.hist., elderly esp.dur.init.dos. per., con-
   pain, hypertens., rhinit., myalg., UTI, priapism, fev., trem., QTc interv.  sinusit., ear/eye infects., tonsillit., cellulit., acarodermatit., subcut.   com.antihypertens./meds.prolong.QTc interv., discont.if S&S of tard.
   prolongat., ac. withdr. sympt.with abrupt cessat., hostil./suic. ideat./   abscess,  onychomycos., decr.WBC & haematocrit, anaem., incr.  dyskines.occur, discont. if sympt.of NMS.occur & admin.appropr.
   self-harm in childr., incr.cerebrovasc. events risk, anx.  eosinophil count, neutropen., thrombocytopen., hypersens., hyper-  treatm., cont.lact, poss.dos.adjustm.with carbamazepine/ pheny-
   Special precautions: Poss.worsen.of depress.& emerg.of suic.  prolactinaem., inappropr.antidiuret., gluc.urine, hyperglycaem., diab.  toin/other concom.hepat. enzyme induc., concom.CYP3A4 inhibits.
   ideat./behav.in maj.depress.disord. wheth. or not admin.antide-  mellit. hyperinsulinaem., incr.bld.cholesterol, hypoglycaem., polydips.,   Interactions: Centr.effs.of other CNS depress.& alcoh. enhanc.,
   press., monit.pts.esp. dur. early ther.& dos.chang.for clinic.worsen./   depress., sleep disord., mania, confus.state, decr.libido, nervouson.,   incr.clear.with concom. thioridazine, decr.plasma conc.with enzyme</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page60.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page56.html">56</a>&nbsp;&nbsp;&nbsp;<a href="page57.html">57</a>&nbsp;&nbsp;&nbsp;<a href="page58.html">58</a>&nbsp;&nbsp;&nbsp;<a href="page59.html">59</a>&nbsp;&nbsp;&nbsp;<a href="page60.html">60</a>&nbsp;&nbsp;&nbsp;<a href="page61.html">61</a>&nbsp;&nbsp;&nbsp;<a href="page62.html">62</a>&nbsp;&nbsp;&nbsp;<a href="page63.html">63</a>&nbsp;&nbsp;&nbsp;<a href="page64.html">64</a>&nbsp;&nbsp;&nbsp;<a href="page65.html">65</a>&nbsp;&nbsp;&nbsp;<a href="page66.html">66</a>
             </td>
             <td width="35%"><a href="page62.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page62.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
